GEBELİK VE DOĞUM SONRASI DÖNEMDE OMEGA-3 KULLANIMI: GÜNCEL LİTERATÜRÜN GÖZDEN GEÇİRİLMESİ

Year 2022, Volume: 9 Issue: 2, - , 01.06.2022

Nilay Şener Tülay Yılmaz Hüsniye Dinç

Abstract

Omega-3 yağ asitleri çoklu doymamış yağ asitlerinin major kaynaklarından biridir. Uzun zincirli çoklu doymamış yağ asitleri, plasental ve fetal lipid ortamlarını değiştirme ve dolayısıyla sağlık sonuçlarını modüle etme konusunda önemli bir potansiyele sahiptir. Yağ asitleri fetal enerji metabolizmasında ve hücre farklılaşmasında, ayrıca enflamatuar ve immün yanıtların düzenlenmesinde kritik bir rol oynar. Ayrıca prostaglandinler ve prostasiklinler, uzun zincirli çoklu doymamış yağ asitlerinin eikosanoid metabolitleri arasındadır. Bunlar plasental büyüme ve gelişmede, gebelik süresinde ve doğum eyleminin başlamasında önemli rol oynar. Plesantal fonksiyonlardaki değişiklikler preeklampsi, gestasyonel diyabet, intrauterin büyüme kısıtlaması gibi çeşitli gebelik komplikasyonlarına yol açar ve olumsuz doğum sonuçlarına neden olur. Gebelikte omega-3’lerin tüketimine ilişkin kılavuzlar mevcut olmakla birlikte hangi haftalarda başlanacağı ve miktarı ile farklı görüşler bulunmaktadır. Mevcut kanıtlar omega-3’lerin gebelik sırasında ve doğum sonu dönemde koruyucu etkileri olduğunu göstermektedir. Omega-3’lerin olumlu etkileri gestasyonel diyabet, preeklampsi, gebelik süresi ve doğum sonu depresyonu azaltmasıdır. Rutin obstetrik bakım sırasında sağlanan sağlık bilgileri ve tavsiyeleri diyette omega-3 alınması üzerinde olumlu bir etkiye sahiptir. Bununla birlikte, literatürde gebelik sırasında diyetle omega-3 tüketimi ile ilgili mevcut eğitim, tavsiye ve reçete uygulamaları ile ilgili bir boşluk bulunmaktadır. Bu derlemede gebelik ve doğum sonu dönemde omega-3 alımına ve etkilerine yönelik güncel bilgilerin gözden geçirilmesi amaçlanmıştır.

Keywords

Omega-3, Gebelik, Doğum Sonu, DHA-EPA

Supporting Institution

YOK

Project Number

YOK

References

• Best, K. P., Gomersall, J., & Makrides, M. (2020). Prenatal nutritional strategies to reduce the risk of preterm birth. Annals of Nutrition and Metabolism, 3(76): 31-39.
• de Seymour, J. V., Jones, M. B., Okesene-Gafa, K. A.M., McKinlay, C. J., Taylor, R. S., Wall, C. R., …McCowan, L. M. (2020). An analysis of omega-3 fatty acid status in a population of pregnant women with obesity, at higher risk of preterm birth. European Journal of Clinical Nutrition, 74(10):1478-1482.
• Middleton, P., Gomersall, J. C., Gould, J. F., Shepherd, E., Olsen, S. F., & Makrides, M. (2018). Omega‐3 fatty acid addition during pregnancy. Cochrane Database of Systematic Reviews, (11).
• Simmonds, L. A., Sullivan, T. R., Skubisz, M., Middleton, P. F., Best, K. P., Yelland, L. N., … Makrides, M. (2020). Omega‐3 Fatty Acid Supplementation in Pregnancy – Baseline Omega‐3 Status and Early Preterm Birth: Exploratory Analysis of a Randomised Controlled Trial. BJOG: An International Journal of Obstetrics & Gynaecology. 127(8): 975–981.
• Wainwright, P. (2002). Dietary essential fatty acids and brain function: A developmental perspective on mechanisms. Proceedings of the Nutrition Society, 61(1): 61-69.
• Montgomery, C., Speake, B. K., Cameron, A., Sattar, N., & Weaver, L. T. (2003). Maternal docosahexaenoic acid supplementation and fetal accretion. British Journal of Nutrition, 90(1):135-145. Duttaroy, A. K., & Basak, S. (2020). Maternal dietary fatty acids and their roles in human placental development. Prostaglandins, Leukotrienes and Essential Fatty Acids, 155, 102080.
• Mocking, R. J., Steijn, K., Roos, C., Assies, J., Bergink, V., Ruhé, H. G., & Schene, A. H. (2020). Omega-3 fatty acid supplementation for perinatal depression: a meta-analysis. The Journal of clinical psychiatry, 81(5).
• Godhamgaonkar, A. A., Wadhwani, N. S., & Joshi, S. R. (2020). Exploring the role of LC-PUFA metabolism in pregnancy complications. Prostaglandins, Leukotrienes and Essential Fatty Acids, 163, 102203.
• Dutta-Roy, A. (2000). Cellular uptake of long-chain fatty acids: role of membrane-associated fatty-acid-binding/transport proteins. CMLS, Cell. Mol. Life Sci. 57:1360–1372.
• Prescott, S. L., & Dunstan, J. A. (2007). Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids, 42(9):801.
• Ortega-Senovilla, H., Schaefer-Graf, U., & Herrera, E. (2020). Pregnant women with gestational diabetes and with well controlled glucose levels have decreased concentrations of individual fatty acids in maternal and cord serum. Diabetologia, 63(4):864-874.
• T.C. Sağlık Bakanlığı, Türkiye beslenme rehberi 2015 (TÜBER). Ankara. https://hsgm.saglik.gov.tr/depo/birimler/saglikli-beslenme-hareketli-hayat-db/Yayinlar/rehberler/2015-beslenme-rehberi.pdf
• U.S. Food and Drug Administration – (FDA) (2020). Advice About Eating Fish for Women Who Are or Might Become Pregnant, Breastfeeding Mothers, and Young Children. Erişim: 02.2021 https://www.fda.gov/food/consumers/advice-about-eating-fish
• Monthé-Drèze, C., Penfield-Cyr, A., Smid, M.C., & Sen, S. (2018). Maternal pre-pregnancy obesity attenuates response to omega-3 fatty acids supplementation during pregnancy. Nutrients, 10(12): 1908.
• Toboła-Wróbel, K., Pietryga, M., Dydowicz, P., Napierała, M., Brązert, J., & Florek, E. (2020). Association of Oxidative Stress on Pregnancy. Oxidative Medicine and Cellular Longevity, 6398520:12.
• Sultana, Z., Maiti, K., Aitken, J., Morris, J., Dedman, L., Smith, R. (2017). Oxidative stress, placental ageing-related pathologies and adverse pregnancy outcomes. American Journal of Reproductive Immunology. 77(5):1–10.
• Mert, I., Oruc, A.S., Yuksel, S., Cakar, E.S., Buyukkagnici, U., Karaer, A., & Danışman, N. (2012). Role of oxidative stress in preeclampsia and intrauterine growth restriction. The journal of obstetrics and gynaecology research, 38(4):658–664.
• Ferguson, K.K., Chen, Y.H., VanderWeele, T.J., McElrath, T.F., Meeker, J.D., Mukherjee, B. (2017). Mediation of the Relationship between Maternal Phthalate Exposure and Preterm Birth by Oxidative Stress with Repeated Measurements across Pregnancy. Environmental health perspectives, Mar;125(3):488-494.
• Bilodeau, J.F., Qin Wei, S., Larose, J., Greffard, K., Moisan, V., Audibert, F., …Fraser, D.W. (2015). Plasma F2-isoprostane class VI isomers at 12–18 weeks of pregnancy are associated with later occurrence of preeclampsia. Free Radical Biology & Medicine, 85: 282-287.
• Sley, E. G., Rosen, E. M., van ‘t Erve, T. J., Sathyanarayana, S., Barrett, E. S., Nguyen, R. H., ... & Ferguson, K. K. (2020). Omega-3 fatty acid supplement use and oxidative stress levels in pregnancy. PloS one, 15(10).
• Aparicio, E., Martín-Grau, C., Bedmar, C., Serrat Orus, N. S., Basora, J., Arija, V., & ECLIPSES Study Group. (2021). Maternal Factors Associated with Levels of Fatty Acids, specifically n-3 PUFA during Pregnancy: ECLIPSES Study. Nutrients, 13(2):317.
• American Diabetes Association (ADA). (2016). Standards of medical care in diabetes. Diabetes Care. The Journal of Clinical and Applied Research And Education, 39 (1): 119.
• Franklin, B.E., Crisler, S.C., Shappley, R., Armour, M.M., McCommon, T.D., Ferry, J.R. (2014). Real-time support of pediatric diabetes self-care by a transport team. Diabetes Care, 37:81–87.
• Gbankoto, A., Mashalla, Y., Nekoua, M. P., Moutairou, K., & Yessoufou, A. (2015). Beneficial effects of omega-3 polyunsaturated fatty acids in gestational diabetes: consequences in macrosomia and adulthood obesity. Journal of Diabetes Research, 731434:11.
• Phang, M., & Skilton, M. R. (2018). Marine Omega-3 fatty acids, complications of pregnancy and maternal risk factors for offspring cardio-metabolic disease. Marine drugs, 16(5):138.
• Wadhwani, N., Patil, V., & Joshi, S. (2018). Maternal long chain polyunsaturated fatty acid status and pregnancy complications. Prostaglandins, Leukotrienes and Essential Fatty Acids, 136: 143-152.
• Zhao, J. P., Levy, E., Shatenstein, B., Fraser, W. D., Julien, P., Montoudis, A., ... & Luo, Z. C. (2016). Longitudinal circulating concentrations of long‐chain polyunsaturated fatty acids in the third trimester of pregnancy in gestational diabetes. Diabetic Medicine, 33(7): 939-946.
• Jamilian, M., Tabassi, Z., Reiner, Ž, Panahandeh, I., Naderi, F., Aghadavod, E., . . . Asemi, Z. (2020). The effects of n-3 fatty acids from flaxseed oil on genetic and metabolic profiles in patients with gestational diabetes mellitus: A randomised, double-blind, placebo-controlled trial. British Journal of Nutrition, 123(7):792-799.
• Samimi, M., Jamilian, M., Asemi, Z., & Esmaillzadeh, A. (2015). Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial. Clinical Nutrition, 34(3): 388–393.
• Delpino, F.M., Figueiredo, L.M., da Silva, B. G. C., da Silva, T. G., Mintem, G. C., Bielemann, R. M., & Gigante, D. P. (2021). Omega-3 supplementation and diabetes: A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition, 1.
• Gravett, M.G. (1984). Causes of preterm delivery. Semin Perinatol, 8(4): 246–257.
• Ramsden, C.E., Makrides, M., Yuan, Z-X., Horowitz, M.S., Zamora, D., Yelland, L.N, ...& Best, K. (2020) Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: can they help predict risk of preterm birth? Prostaglandins Leukot Essent Fatty Acids. 153,102041.
• Vinding, R. K., Stokholm, J., Sevelsted, A., Chawes, B. L., Bønnelykke, K., Barman, M., ... & Bisgaard, H. (2019). Fish oil supplementation in pregnancy increases gestational age, size for gestational age, and birth weight in infants: a randomized controlled trial. The Journal of nutrition, 149(4): 628-634.
• Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., ... & Gibson, R. (2019). A randomized trial of prenatal n− 3 fatty acid supplementation and preterm delivery. New England Journal of Medicine, 381(11): 1035-1045.
• Dhillon, P., Kaur, I., & Singh, K. (2021). Pregnancy-induced hypertension: Role of drug therapy and nutrition in the management of hypertension. PharmaNutrition, 15, 100251.
• Wadhwani, N. S., Narang, A. S., Mehendale, S. S., Wagh, G. N., Gupte, S. A., & Joshi, S. R. (2016). Reduced maternal erythrocyte long chain polyunsaturated fatty acids exist in early pregnancy in preeclampsia. Lipids, 51(1): 85-94.
• Geleijnse, J. M., Giltay, E. J., Grobbee, D. E., Donders, A. R., & Kok, F. J. (2002). Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. Journal of Hypertension, 20(3): 1493-1499.
• Miller, P. E., Van Elswyk, M., & Alexander, D. D. (2014). Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. American journal of hypertension, 27(7): 885-896.
• Lim, W. Y., Chong, M., Calder, P. C., Kwek, K., Chong, Y. S., Gluckman, P. D., ... & Pan, A. (2015). Relations of plasma polyunsaturated Fatty acids with blood pressures during the 26th and 28th week of gestation in women of Chinese, Malay, and Indian ethnicity. Medicine, 94(9).
• Imhoff‐Kunsch, B., Briggs, V., Goldenberg, T., & Ramakrishnan, U. (2012). Effect of n‐3 long‐chain polyunsaturated fatty acid intake during pregnancy on maternal, infant, and child health outcomes: a systematic review. Paediatric and perinatal epidemiology, 26: 91-107.
• Chen, B., Ji, X., Zhang, L., Hou, Z., Li, C., & Tong, Y. (2015). Fish oil supplementation does not reduce risks of gestational diabetes mellitus, pregnancy-induced hypertension, or pre-eclampsia: a meta-analysis of randomized controlled trials. Medical science monitor: international medical journal of experimental and clinical research, 21: 2322-2330.
• Kinshella, M. L. W., Moore, S. E., & Elango, R. (2021). The missing focus on women’s health in the First 1,000 Days approach to nutrition. Public Health Nutrition, 24(6): 1526-1530.
• Koletzko, B., Cetin, I., Brenna, J. T., & Perinatal Lipid Intake Working Group. (2007). Dietary fat intakes for pregnant and lactating women. British Journal of Nutrition, 98(5): 873-877.
• Zhang, Z., Fulgoni, V.L.III , Kris-Etherton, P.M., Mitmesser, S.H. (2018). Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant Women: An Analysis of NHANES 2001–2014. Nutrients, 10(4): 416.
• Dennehy, C. (2011). Omega‐3 fatty acids and ginger in maternal health: Pharmacology, efficacy, and safety. Journal of Midwifery & Women’s Health, 56(6): 584-590.
• Fleddermann, M., Demmelmair, H., Grote, V., Nikolic, T., Trisic, B., & Koletzko, B. (2014). Infant formula composition affects energetic efficiency for growth: the BeMIM study, a randomized controlled trial, Clinical nutrition, 33(4): 588-595.
• Koletzko, B., Lien, E., Agostoni, C., Böhles, H., Campoy, C., Cetin, I., ... & Uauy Dagach-Imbarack, R. (2008). The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. Journal of Perinatal Medicine, 36(1).
• Zhang, X., Zhang, M., Lin, T., Zhao, J., Luo, Z., Hou, J., ... & Chen, L. (2021). Relationship between traditional maternal diet pattern and breastmilk composition of rural lactating women during the first month postpartum in Shigatse, Tibet. Food Science & Nutrition, 9(8): 4185-4198.
• Gellert, S., Schuchardt, J. P., & Hahn, A. (2016). Higher omega-3 index and DHA status in pregnant women compared to lactating women–Results from a German nation-wide cross-sectional study. Prostaglandins, Leukotrienes and Essential Fatty Acids, 109: 22-28.
• Reimers, A., & Ljung, H. (2019). The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders. Therapeutic advances in psychopharmacology, 9:1-18.
• Guu, T. W., Mischoulon, D., Sarris, J., Hibbeln, J., McNamara, R. K., Hamazaki, K., ... & Su, K. P. (2019). International Society for Nutritional Psychiatry Research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder. Psychotherapy and psychosomatics, 88(5): 263-273.
• Guu, T. W., Mischoulon, D., Sarris, J., Hibbeln, J., McNamara, R. K., Hamazaki, K., ... & Su, K. P. (2020). A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. Journal of affective disorders, 265: 233-238.
• Larrieu, T., & Layé, S. (2018). Food for mood: Relevance of nutritional omega-3 fatty acids for depression and anxiety. Frontiers in physiology, 9, 1047.
• Firth, J., Teasdale, S. B., Allott, K., Siskind, D., Marx, W., Cotter, J., ... & Sarris, J. (2019). The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials. World Psychiatry, 18(3): 308-324.
• Zhang, M. M., Zou, Y., Li, S. M., Wang, L., Sun, Y. H., Shi, L., ... & Li, S. X. (2020). The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials. Translational psychiatry, 10(1): 1-9.
• Hamazaki, K., Matsumura, K., Tsuchida, A., Kasamatsu, H., Tanaka, T., Ito, M., & Inadera, H. (2020). Dietary intake of fish and n-3 polyunsaturated fatty acids and risk of postpartum depression: A nationwide longitudinal study – the Japan Environment and Children's Study (JECS). Psychological Medicine, 50(14): 2416-2424.
• Nishi, D., Su, K.P., Usuda, K., Chang, J.P.C., Chiang, Y.J., Chen, H.T., ... & Matsuoka, Y.J. (2019). The efficacy of omega-3 fatty acids for depressive symptoms among pregnant women in Japan and Taiwan: a randomized, double-blind, placebo-controlled trial (SYNCHRO; NCT01948596). Psychotherapy and psychosomatics, 88(2): 122-124.
• Suradom, C., Suttajit, S., Oon-Arom, A., Maneeton, B., & Srisurapanont, M. (2020). Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation for prevention and treatment of perinatal depression: a systematic review and meta-analysis of randomized-controlled trials. Nordic Journal of Psychiatry, 75(4).
• Wei-Hong, L., Cheng-Gui, Z., Peng-Fei, G., Heng, L., & Jian-Fang, Y. (2017). Omega-3 fatty acids as monotherapy in treating depression in pregnant women: a meta-analysis of randomized controlled trials. Iranian journal of pharmaceutical research: IJPR, 16(4), 1593.